IJR News — today's news from every sideDr. David Crean Book Guides Biopharma Leaders on Commercialization — 17hA new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.
Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans. IJRWall Street Is Ready To Invest In America’s Energy Future. If Washington Permits It.Jeremy Harrell · 4 min · 1h
On X · @BoySpyceBoy Spyce Offers Apology to Influencers Except Dami ForeignNigerian artist Boy Spyce proposes an X Space to apologize to blocked influencers but excludes Dami Foreign. Reactions are mostly skeptical or mocking rather than polarized, with advice to focus on music instead of pandering.342 likes · 55m